Vimian Group AB (publ) (VIMGF)
OTCMKTS · Delayed Price · Currency is USD
3.010
-1.290 (-30.00%)
At close: Sep 10, 2025
Vimian Group AB Market Cap
Vimian Group AB has a market cap or net worth of $1.65 billion as of November 7, 2025. Its market cap has decreased by -20.34% in one year.
Market Cap
1.65B
Enterprise Value
1.91B
Revenue
493.96M
Ranking
n/a
PE Ratio
44.55
Stock Price
$3.01
Market Cap Chart
Since June 18, 2021, Vimian Group AB's market cap has decreased from 3.65B to 1.65B, a decrease of -54.84%. That is a compound annual growth rate of -16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 1.65B | -12.68% |
| Dec 30, 2024 | 1.89B | 40.53% |
| Dec 29, 2023 | 1.34B | 23.45% |
| Dec 30, 2022 | 1.09B | -68.17% |
| Dec 30, 2021 | 3.41B | -6.35% |
| Jun 18, 2021 | 3.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 674.13M |
| Glass House Brands | 579.39M |
| Northwest Biotherapeutics | 374.83M |
| American Oncology Network | 326.52M |
| Nika Pharmaceuticals | 311.89M |
| Silence Therapeutics | 310.80M |
| CytoDyn | 308.64M |